Dr. Walsh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
705 Riley Hospital Dr
Indianapolis, IN 46202Phone+1 317-948-7450Fax+1 317-968-1193
Education & Training
- Indiana University School of MedicineResidency, Medical Genetics and Genomics, 1996 - 1998
- Indiana University School of MedicineFellowship, Child Neurology, 1989 - 1992
- Indiana University School of MedicineResidency, Pediatrics, 1987 - 1989
- Indiana University School of MedicineClass of 1987
Certifications & Licensure
- IN State Medical License 1989 - 2025
- OH State Medical License 1993 - 2011
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- Indianapolis Monthly Castle Connolly, 2010-2013
Publications & Presentations
PubMed
- 30 citationsSteroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutationMark P. Gorman, Meredith R. Golomb, Laurence E. Walsh, Grace M. Hobson, James Y. Garbern
Neurology. 2007-04-17 - 17 citationsDelineating the molecular and phenotypic spectrum of the SETD1B-related syndromeMarjolein J.A. Weerts, Kristina Lanko, Francisco J. Guzmán-Vega, Adam Jackson, Reshmi Ramakrishnan
Genetics in Medicine. 2021-08-03 - 39 citationsWDR26 Haploinsufficiency Causes a Recognizable Syndrome of Intellectual Disability, Seizures, Abnormal Gait, and Distinctive Facial FeaturesCara M. Skraban, Constance F. Wells, Preetha Markose, Megan T. Cho, Addie I. Nesbitt
American Journal of Human Genetics. 2017-07-06
Press Mentions
- Interview: “We Intend to Ultimately Develop a Daily Use Oral Care Product with a Natural Substance”March 6th, 2019
- Neurologists at IU Administer First-of-Its-Kind FDA-Approved Gene TherapyJanuary 25th, 2024
Grant Support
- Epoxide Hydrolase And Phenytoin Induced TeratogenesisNational Institute Of Dental &Craniofacial Research1998–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: